SCHEMBL4255386

SCHEMBL4255386

CC(C)[C@@H](COc1ccc(C(=S)NO)cc1)NC(=O)c1cc2ccccc2s1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.48
TAS1R1 Q7RTX1 2/20 0.48
HDAC1 Q13547 5/20 0.47
HDAC3 O15379 2/20 0.47
HDAC4 P56524 2/20 0.47
HDAC7 Q8WUI4 2/20 0.47
HDAC2 Q92769 2/20 0.47
HDAC10 Q969S8 2/20 0.47
HDAC11 Q96DB2 2/20 0.47
HDAC8 Q9BY41 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
HDAC9 Q9UKV0 2/20 0.47
HDAC5 Q9UQL6 2/20 0.47
PIN1 Q13526 6/20 0.43
KLKB1 P03952 1/20 0.42
RAB9A P51151 1/20 0.40
UTS2R Q9UKP6 1/20 0.40
CTSB P07858 1/20 0.39
CTSS P25774 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL444127 0.91 HDAC1 (0.53) TAS1R3TAS1R1HDAC1HDAC3HDAC4
SCHEMBL4254170 0.90 TAS1R3 (0.49) TAS1R3TAS1R1HDAC1HDAC3HDAC4
SCHEMBL4253875 0.90 TAS1R3 (0.49) TAS1R3TAS1R1HDAC1HDAC3HDAC4
SCHEMBL4255500 0.86 HDAC1 (0.47) TAS1R3TAS1R1HDAC1HDAC3HDAC4
SCHEMBL444314 0.81 HDAC1 (0.55) TAS1R3TAS1R1HDAC1HDAC3HDAC4
SCHEMBL445398 0.81 HDAC1 (0.55) TAS1R3TAS1R1HDAC1HDAC3HDAC4
SCHEMBL4252262 0.79 HDAC1 (0.52) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL4251127 0.78 OPRM1 (0.49) TAS1R3TAS1R1HDAC1HDAC3HDAC4
SCHEMBL4252895 0.78 OPRM1 (0.49) TAS1R3TAS1R1HDAC1HDAC3HDAC4
SCHEMBL4251113 0.78 RAB9A (0.57) HDAC1HDAC3HDAC4HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090023798-A1 THIOHYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2009-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023798-A1 THIOHYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC8, HDAC3 TAS1R3 3722/4885TAS1R1 3753/4885HDAC1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.